Bristol Myers Squibb reported $2.97B in Trade Creditors for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Amgen AMGN:US $ 1396M 25M
Biogen BIIB:US $ 430.4M 24.5M
Bristol Myers Squibb BMY:US $ 2972M 259M
Catalent CTLT:US $ 365.7M 8.8M
Coherus Biosciences CHRS:US $ 15.48M 0.28M
Drreddys Laboratories RDY:US $ 22833M 3795M
Eli Lilly And LLY:US $ 1639.6M 32.9M
Endo International Ordinary Shares ENDP:US $ 104.52M 10.12M
Gw Pharmaceuticals GWPH:US $ 16.67M 5.2M
Horizon Pharma HZNP:US $ 42.99M 5.28M
Intercept Pharmaceuticals ICPT:US $ 12.58M 12.01M
JAZZ PHA JAZZ:US $ 77.74M 50.79M
Johnson & Johnson JNJ:US $ 8503M 1002M
Lannett LCI:US $ 32.6M 10.06M
Medtronic MDT:US $ 1816M 86M
Novartis NOVN:VX 5.04B 363M
Phibro Animal Health PAHC:US $ 62.8M 0.5M
Prestige Brands PBH:US $ 45.98M 16.86M
Regeneron Pharmaceuticals REGN:US $ 542.9M 67.4M
Revance Therapeutics RVNC:US $ 12.66M 4.8M
Teva Pharmaceutical Industries TEVA:US $ 1692M 64M
Zoetis ZTS:US $ 346M 111M